NeuroSense Therapeutics Ltd. Stock News

Emerging Science (Late-Breaker Equivalent) Abstract To Be Presented At 5:30PM Local Time Highlights Phase 2 PARADIGM Outcomes CAMBRIDGE, Mass. , April 12, 2024 /PRNewswire/ -- NeuroSense Therapeutics

- Last patient completed the double-blind segment of PARADIGM, a Phase 2b ALS Trial - Clinical efficacy top-line results from PARADIGM expected in December 2023 CAMBRIDGE, Mass. , Nov. 9, 2023 /PRNew

NeuroSense Therapeutics will report Phase 2b trial data for its ALS drug candidate, PrimeC, in Q4 2023. Topline data of this trial may well be the company's most pivotal event since its IPO at the end

Biomarkers show potential efficacy PrimeC is currently being evaluated for the treatment of ALS in a Phase 2b study with topline results expected in H2 2023 Phase 2 double-blind proof-of-concept AD st

Stock Market News Has These Penny Stocks On Traders' Watch Lists This Week. The post Penny Stocks To Buy Now?

Use these tips for making money with penny stocks right now The post 3 Ways to Make Money With Penny Stocks Right Now  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks

NeuroSense (NASDAQ: NRSN ) stock is taking off on Thursday as investors react to data from a biomarker study concerning Alzheimer's disease ( AD ). The clinical trial covers the use of NeuroSense's co

CAMBRIDGE, Mass. , Oct. 27, 2022 /PRNewswire/ -- NeuroSense Therapeutics Ltd.

Penny stocks to buy [or avoid] after Biogen Alzheimer's news. The post 4 Alzheimer's Penny Stocks To Watch After Biogen Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Informatio

Biomarker data to be presented provide indication of PrimeC's efficacy in ALS Phase IIb PARADIGM ALS trial's primary endpoints include biomarkers and ALS-related hallmarks Topline results expected H1

NRSN stock is on the move in the wake of encouraging clinical results for a novel drug combination to treat Alzheimer's disease. The post Why Is NeuroSense (NRSN) Stock Up 35% Today?

Penny stocks for your watch list with the stock market down today. The post 3 Penny Stocks To Watch While The Stock Market Is Down appeared first on Penny Stocks to Buy, Picks, News and Information |

NeuroSense Therapeutics Ltd (NASDAQ: NRSN) has announced results from a biomarker study to evaluate the potential of CogniC, a combination drug for Alzheimer's disease (AD). Earlier this week, Neur

Penny stocks to buy or avoid right now? You decide after seeing the latest updates from 3 companies.

Check these three penny stocks out right now The post Best Penny Stocks to Buy as June Ends? 3 to Watch  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.